Transcranial cell stimulation experiment model and method
By constructing a transcranial cell stimulation experimental model, using a strong magnetic field to stimulate cells and analyze protein expression levels, the shortcomings of dTMS in deep stimulation characteristics and coil design were overcome, providing a new therapeutic perspective and strategy.
Patent Information
- Application Number
- CN202511426591.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-30
- Publication Date
- 2026-02-06
AI Technical Summary
Current technologies lack comprehensive experimental models to optimize the deep stimulation characteristics of transcranial magnetic stimulation (dTMS) in the human brain and its coil design, which affects its therapeutic efficacy and safety.
A transcranial cell stimulation experimental model was constructed, including a support structure and a placement platform with adjustable angle and height, with built-in stimulation coils and a power supply unit. The model stimulates cells by generating a strong magnetic field of 1T to 4T, and the expression levels of p-CREB and CaMKII proteins were analyzed by combining Western blot technology.
This study simulated and validated non-invasive brain stimulation techniques, enriched our understanding of dTMS, and provided new scientific evidence and clinical application strategies for the treatment of neuropsychiatric diseases, especially demonstrating remarkable effects in the regulation of deep brain regions.
Smart Images

Figure CN121483137A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biomedical engineering technology, specifically to a transcranial cell stimulation experimental model and method. Background Technology
[0002] In recent years, with the continuous development of neuroscience, non-pharmacological interventions have played an increasingly important role in the treatment of neuropsychiatric disorders. While traditional drug therapies have shown some effectiveness in treating these disorders, they suffer from poor efficacy and severe side effects, significantly limiting patient outcomes and quality of life, and also posing challenges to the rational use of medical resources. Therefore, seeking more effective and safer treatment methods has become one of the important directions in current research on neuropsychiatric disorders.
[0003] Against this backdrop, deep brain region neuromodulation techniques have attracted significant attention as an emerging non-pharmacological intervention. Transcranial magnetic stimulation (TMS) is one such technique, which induces currents by applying a transient magnetic field to the cerebral cortex, thereby altering the electrical potential of cortical nerve cell membranes and triggering neuromodulation. Compared to traditional drug therapy, TMS offers advantages such as being painless, non-invasive, safe, and reliable, and has been widely applied in neuroscience, neurology, psychiatry, rehabilitation medicine, and medical psychology. TMS modulates neuronal activity by applying magnetic fields to specific brain regions. When the induced electric field generated by the transcranial magnetic coils in the brain tissue reaches a specific threshold, it can activate or inhibit neuronal activity in that region, thereby affecting brain metabolism and function. This non-invasive and controllable neuromodulation method provides new ideas and methods for the treatment of neuropsychiatric disorders.
[0004] Clinical trials and scientific research have confirmed that dTMS technology has significant therapeutic effects on a range of complex neuropsychiatric disorders. Specifically, dTMS has shown positive therapeutic effects in alleviating major depressive disorder, improving symptoms of schizophrenia, reducing dystonia, alleviating chronic migraines, and as an adjunct treatment for autism spectrum disorders. These disorders are often related to dysfunction in deep brain structures such as the limbic system and basal ganglia. dTMS can improve patient symptoms and enhance quality of life by influencing neural activity in these areas. Currently, the development of dTMS technology is moving towards greater focus and personalized treatment. By improving coil design and optimizing stimulation parameters, researchers are working to improve the therapeutic effects of dTMS, reduce side effects, and explore its potential applications in a wider range of diseases. Furthermore, by integrating cutting-edge neuroimaging technologies, such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), dTMS has the potential to improve the precise localization of brain regions and optimize treatment outcomes. These imaging technologies can provide real-time information about brain activity, thereby making dTMS treatment more precise, which is expected to improve treatment effectiveness and reduce side effects, thus supporting personalized medicine.
[0005] Nevertheless, as the potential of dTMS technology is continuously explored, systematic research on the deep stimulation characteristics of dTMS in the actual human brain and its coil design is still insufficient, especially the lack of a comprehensive experimental model to optimize the application of dTMS stimulation. Summary of the Invention
[0006] The technical problem to be solved by the present invention is to provide a transcranial cell stimulation experimental model and method to overcome the shortcomings of the prior art.
[0007] The technical solution of the present invention to solve the above-mentioned technical problems is as follows: A transcranial cell stimulation experimental model includes: a support structure and an openable skull model. The support structure supports the skull model and its upper end enters the skull model. A placement platform fixed to the support structure and adjustable in angle and height is arranged inside the skull model. Cell culture dishes are placed on the placement platform. An elliptical stimulation coil is arranged on each side of the skull model. Each stimulation coil is electrically connected to a power supply unit. The power supply unit is used to rapidly discharge to the two stimulation coils to induce a brief strong pulse current in the stimulation coils and to form a strong magnetic field of 1T to 4T around the stimulation coils.
[0008] The beneficial effects of this invention are as follows: A skull model similar to the human skull is constructed, and SH-SY5Y cells, as the target, are placed in a cell culture dish within the skull model. The placement platform and the angle and height of the cell culture dish are adjusted to simulate SH-SY5Y cells representing different deep structures of the brain. Then, a power supply unit rapidly discharges to two stimulation coils to induce a brief, strong pulse current within the stimulation coils, forming a strong magnetic field of 1T to 4T around the stimulation coils. The generated strong magnetic field stimulates the SH-SY5Y cells in the cell culture dish. Western blot technology is then used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation, thereby clarifying the stimulation effect and achieving experimental simulation and verification. This not only enriches the understanding of non-invasive brain stimulation technology but also provides new scientific evidence for the treatment of related neuropsychiatric diseases and offers new perspectives and potential clinical application strategies for the future regulation of deep brain nuclei.
[0009] Based on the above technical solution, the present invention can be further improved as follows.
[0010] Furthermore, the skull model was 3D printed using polylactic acid.
[0011] The further beneficial effects of the above are as follows: PLA is a biodegradable thermoplastic synthetic material derived from sustainable resources such as corn starch. It not only has excellent biocompatibility, but also exhibits low biotoxicity and excellent mechanical properties during the printing process. These characteristics make PLA an ideal choice for biomedical research, especially in situations where it is necessary to simulate the hardness and surface properties of human tissue.
[0012] Furthermore, the support structure includes: a column and a base. The base is located outside the skull model, and the lower end of the column is located outside the skull model and fixed to the base. The upper end of the column penetrates into the skull model from below the back of the skull. At least one assembly hole matching the diameter of the column is opened on the placement platform. The placement platform is fitted onto the column through the assembly hole. A limiting rod is provided on the column radially below the placement platform. Multiple washers are fitted on the column between the limiting rod and the placement platform.
[0013] The further beneficial effect of adopting the above is that the angle and height of the cell culture dish can be adjusted to simulate SH-SY5Y cells as different deep structures of the brain.
[0014] Furthermore, the stimulation coil is formed by spirally winding a wire into an elliptical shape, or by stacking multiple elliptical coils concentrically. The stimulation coil is made of copper, with 6 turns, a short inner diameter of 5mm to 15mm, a long inner diameter of 15mm to 40mm, a wire width of 1.5mm, a wire height of 1mm, an axial spacing of 2mm, and a radial spacing of 1mm.
[0015] The further beneficial effects of the above-mentioned method are: better deep penetration ability, especially excellent effect on 5cm deep stimulation, opening up new treatment avenues for subsequent clinical treatment of diseases related to consciousness disorders and cognitive dysfunction.
[0016] Furthermore, the power supply unit includes: a main control board, two DC-DC boost modules, two capacitor banks, two IGBT modules, and two diode rectifiers. The main control board is electrically connected to each of the two DC-DC boost modules, and each of the two DC-DC boost modules is electrically connected to a switching power supply. The two switching power supplies are each connected to an external 220V AC mains power supply. Each of the two DC-DC boost modules is electrically connected to a capacitor bank and charges the capacitor bank to a voltage of 400V to 1000V. Each of the two capacitor banks is electrically connected to an IGBT module, each of the two IGBT modules is electrically connected to a diode rectifier, and each of the two diode rectifiers is electrically connected to a stimulation coil. The energy in the capacitor banks is rapidly released in pulse form through the IGBT modules and flows to the stimulation coil through the diode rectifiers to induce a brief, strong pulse current in the stimulation coil and form a strong magnetic field of 1T to 4T around the stimulation coil.
[0017] The further beneficial effects of adopting the above are as follows: The main control board, as the central hub of the system operation, is responsible for coordinating and directing the collaborative work of all hardware components. When it receives parameter instructions, the main control board starts the DC-DC boost module, which charges the capacitor bank until it reaches the preset voltage threshold. The capacitor bank releases the stored energy at an appropriate time to generate a high-intensity electromagnetic pulse. Subsequently, the main control board, through precise control of the IGBT module, rapidly releases the energy in the capacitor bank in the form of pulses, which flow to the stimulation coil through the diode rectifier to induce a brief strong pulse current in the stimulation coil and form a strong magnetic field of 1T to 4T around the stimulation coil. The generated strong magnetic field stimulates the SH-SY5Y cells in the cell culture dish. Due to its fast switching response capability, the IGBT module 240 can generate the required pulse voltage in a short time, thereby forming a strong electromagnetic pulse around the stimulation coil. By adjusting the pulse output voltage of the IGBT module, the intensity of the electromagnetic field can be precisely controlled to achieve precise stimulation of different depth regions.
[0018] Furthermore, the stimulation coil was placed close to the skull model.
[0019] Based on the above technical solution, the present invention also provides a transcranial cell stimulation experimental method, which uses the above-mentioned transcranial cell stimulation experimental model and includes the following steps: S10. First, the cultured SH-SY5Y cells are pretreated with retinoic acid to promote the differentiation of SH-SY5Y cells into neuron-like cells, and then placed in a cell culture dish at the corresponding depth under the scalp. S20. The power supply unit rapidly discharges to the two stimulation coils to induce a brief, strong pulse current in the stimulation coils and forms a strong magnetic field of 1T to 4T around the stimulation coils. The generated strong magnetic field stimulates SH-SY5Y cells in the cell culture dish. Then, Western blot is used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation.
[0020] The further beneficial effects of adopting the above methods are: it can meet the requirements of experimental simulation and verification, not only enriching the understanding of non-invasive brain stimulation technology, but also providing new scientific evidence for the treatment of related neuropsychiatric diseases, and providing new perspectives and potential clinical application strategies for the future regulation of deep brain nuclei.
[0021] Furthermore, the SH-SY5Y cell culture method is as follows: SH-SY5Y cells were placed in DMEM medium with 10% fetal bovine serum and 1% penicillin-streptomycin solution added, and cultured at a constant temperature of 37°C. The incubator was kept in a humid environment of 5% CO2 to simulate the in vivo environment. When the SH-SY5Y cell population reached 80% confluence, cell separation was performed using a 0.25% trypsin-EDTA mixture. The separated cells were collected in centrifuge tubes and then deposited under decelerated centrifugation. After removing the supernatant, the cells were washed with PBS buffer solution to remove the remaining trypsin-EDTA. Cells were resuspended in fresh DMEM medium and transferred to new culture containers at an appropriate ratio. The transferred cells were placed in a 37°C, 5% CO2 incubator to encourage them to reattach and grow. The culture medium was changed every 2 to 3 days. During the culture period, the cell morphology and growth were checked regularly using an inverted microscope, and the culture data were recorded in detail.
[0022] Furthermore, the stimulation pattern for SH-SY5Y cells was as follows: stimulation was performed once a day for 3 consecutive days at a frequency of 20 Hz for a duration of 30 min.
[0023] Furthermore, the following method was used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation using Western blot technology: First, after reaching an appropriate number of passages, cells were fixed using pre-cooled PBS buffer containing 1% formaldehyde to maintain the native state of proteins. After fixation, cells were collected and centrifuged to precipitate the protein, followed by treatment with lysis buffer containing inhibitors to separate total protein. After treatment, cell samples were incubated under ice-cold conditions to ensure complete cell breakdown and protein release. Insoluble matter was removed by centrifugation, and the supernatant was collected. Protein concentration was determined using the BCA protein quantification method. Subsequently, the protein samples were mixed with 4×SDS-PAGE loading buffer and boiled in water for 5 min to denature the proteins. The denatured protein samples were analyzed by SDS-PAGE gel electrophoresis, sorted according to their molecular weight, and the obtained proteins were transferred to PVDF membranes for further analysis. Subsequently, the membrane was treated in a blocking solution rich in bovine serum albumin to reduce nonspecific binding. After this treatment, the membrane was incubated overnight at 4°C with p-CREB and CaMKII primary antibodies. After the primary antibody reaction, the membrane was repeatedly washed with PBS-T washing solution to remove unbound primary antibodies. Next, the membrane and HRP-conjugated secondary antibody were incubated at room temperature for 1-2 hours. After the secondary antibody incubation was completed, the membrane was washed again with PBS-T washing solution to remove excess secondary antibody. Finally, chemiluminescent substrates were used for development, and signals were captured using an X-ray film imaging system to quantitatively analyze the expression levels of p-CREB and CaMKII, while also detecting β-actin protein expression. Attached Figure Description
[0024] Figure 1 Assembly drawing for the supporting structure and skull model; Figure 2 Assembly drawing for placing the platform and removing the skull model; Figure 3 This is a schematic diagram of the first structure of the stimulation coil; Figure 4 This is a diagram of the second structure of the stimulation coil; Figure 5 This is a schematic diagram including a power supply unit, stimulation coil, heat dissipation components, and a computer. Figure 6 The circuit diagram includes a power supply unit, stimulation coil, heat dissipation components, and a computer. Figure 7 This is a diagram illustrating the stimulation pattern of two stimulation coils. Figure 8 Partial physical components of the transcranial cell stimulation experimental model Figure 1 ; Figure 9 Partial physical components of the transcranial cell stimulation experimental model Figure 2 ; Figure 10 This is an experimental diagram of a transcranial cell stimulation experimental model; Figure 11 The image shows the results of a Western blot experiment at a stimulation depth of 1 cm. Note: (A) represents the expression of p-CREB and CaMKII proteins after the three treatment groups, (B) and (C) represent the quantitative expression of p-CREB and CaMKII proteins, respectively. β-actin was used as an internal control, and the gray values of the protein bands were normalized. * represents P≤0.05, ** represents P≤0.001, and both are comparisons between the stimulation group and the control group.
[0025] The attached diagram lists the components represented by each number as follows: 1. Stimulation coil; 2. Power supply unit; 210. Main control board; 220. DC-DC boost module; 230. Capacitor bank; 240. IGBT module; 250. Diode rectifier; 260. Switching power supply; 3. Computer; 4. Heat dissipation component; 5. Support structure; 510. Column; 520. Base; 6. Skull model; 7. Placement platform. Detailed Implementation
[0026] The principles and features of the present invention are described below with reference to the accompanying drawings. The examples given are only for explaining the present invention and are not intended to limit the scope of the present invention.
[0027] Example 1 like Figures 1-10 As shown, a transcranial cell stimulation experimental model includes: a support structure 5 and a skull model 6 with an openable skull. The support structure 5 supports the skull model 6, and its upper end extends into the skull model 6. A placement platform 7, fixed to the support structure 5 and adjustable in angle and height, is placed inside the skull model 6. Cell culture dishes are placed on the placement platform 7, containing SH-SY5Y cells pretreated with retinoic acid (RA). An elliptical stimulation coil 1 is arranged obliquely on each side of the skull model 6. Each stimulation coil 1 is electrically connected to a power supply unit 2. The power supply unit 2 rapidly discharges to the two stimulation coils 1 to induce a brief, strong pulse current within the stimulation coil 1 and forms a strong magnetic field of 1T to 4T around the stimulation coil 1 to stimulate the SH-SY5Y cells in the cell culture dish. Western spectroscopy can then be used to... Blot analysis was used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation, thus simulating stimulation of the claustrum and part of the hippocampus in deep brain regions (5 cm depth).
[0028] A skull model 6, similar to the human skull, was constructed. SH-SY5Y cells, the target cells, were placed in a cell culture dish within the skull model 6. The placement platform 7 and the angle and height of the cell culture dish were adjusted to simulate different deep brain structures (different stimulation depths, such as 1 cm and 5 cm, with 1 cm representing superficial stimulation and 5 cm representing deep stimulation) using SH-SY5Y cells. A power supply unit 2 rapidly discharged to two stimulation coils 1 to induce a brief, strong pulse current within the coils, creating a strong magnetic field of 1T to 4T around the coils. This strong magnetic field stimulated the SH-SY5Y cells in the cell culture dish. Western blot analysis was then used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation, thus clarifying the stimulation effect and achieving experimental simulation and verification. This not only enriches our understanding of non-invasive brain stimulation techniques but also provides new scientific evidence for the treatment of related neuropsychiatric diseases and offers new perspectives and potential clinical application strategies for the future regulation of deep brain nuclei.
[0029] Example 2 like Figure 1 , Figure 2 As shown, this embodiment is a further optimization based on embodiment 1, and its specific content is as follows: The skull model 6 was formed using 3D printing, a technology that allows for the precise construction of complex biological structures to simulate real biological environments. After in-depth analysis, polylactic acid (PLA) was ultimately chosen as the printing material for 3D printing. PLA is a biodegradable thermoplastic synthetic material derived from sustainable resources such as corn starch. It not only has excellent biocompatibility but also exhibits low biotoxicity and excellent mechanical properties during the printing process. These characteristics make PLA an ideal choice for biomedical research, especially in situations where it is necessary to simulate the hardness and surface properties of human tissue.
[0030] Based on the "New York Head" model (a high-precision finite element model developed by Yu Huang and Lucas C. Parra, etc.), the skull model design stage 6 ensured the model's closure, avoiding internal voids and overlapping surfaces. These details are crucial for ensuring a smooth printing process. After the model was created, it was exported as an .STL file. Subsequently, slicing software such as Cura was used to slice the model. This step converts the model into a sequence of instructions that the printer can recognize. During the slicing process, the model was carefully inspected to ensure there were no errors or areas that needed repair. Regarding the adjustment of printing parameters, parameters such as layer height, infill density, and printing speed were optimized according to the characteristics of PLA and the performance of the 3D printer used. The adjustment of parameters has a direct impact on the surface quality, strength, and printing time of the final model.
[0031] The designed placement platform 7 can accommodate the smallest culture dish in the laboratory, with a minimum diameter of 3.5 cm. The placement platform 7 has various lengths to accommodate cell culture dishes of different sizes, thereby simulating and locating the stimulation effects of multiple deep brain nuclei.
[0032] The support structure 5 includes a column 510 and a base 520. The base 520 is located outside the skull model 6. The lower end of the column 510 is located outside the skull model 6 and is fixed to the base 520. The upper end of the column 510 passes through the skull model 6 from below the back of the head and enters the skull model 6. The placement platform 7 has at least one assembly hole that matches the diameter of the column 510. The placement platform 7 is fitted onto the column 510 through the assembly hole. A limiting rod is provided on the column 510 radially below the placement platform 7. Multiple washers are fitted on the column 510 between the limiting rod and the placement platform 7.
[0033] Example 3 like Figure 3 , Figure 4 As shown, this embodiment is a further optimization based on embodiment 1 or 2, and its specific content is as follows: The stimulation coil 1 is made of wires wound in a spiral to form an elliptical shape, or is made of multiple elliptical coils stacked concentrically. The stimulation coil 1 is made of copper, has 6 turns, a short inner diameter of 5mm to 15mm, a long inner diameter of 15mm to 40mm, a wire height of 1mm, an axial spacing of 2mm, and a radial spacing of 1mm.
[0034] Example 4 like Figure 5 , Figure 6 As shown, this embodiment is a further optimization based on embodiment 1, 2, or 3, and its specific content is as follows: The power supply unit 2 includes: a main control board 210, two DC-DC boost modules 220, two capacitor banks 230, two IGBT (Insulated Gate Bipolar Transistor) modules 240, and two diode rectifiers 250. The main control board 210 is electrically connected to the two DC-DC boost modules 220, and each of the two DC-DC boost modules 220 is electrically connected to a switching power supply 260. The two switching power supplies 260 are each connected to a 220V AC mains power supply. The switching power supply 260 can be a 90V switching power supply. Each of the two DC-DC boost modules 220 is electrically connected to a capacitor bank 230 and charges the capacitor bank 230 so that its voltage reaches a threshold of 400V to 1000V. Each of the two capacitor banks 230 is electrically connected to an IGBT module 240, each of the two IGBT modules 240 is electrically connected to a diode rectifier 250, and each of the two diode rectifiers 250 is electrically connected to an excitation coil 1. As the central hub of the system, the main control board 210 is responsible for coordinating and directing the collaborative work of all hardware components. Upon receiving parameter commands, the main control board 210 activates the DC-DC boost module 220, which charges the capacitor bank 230 until a preset voltage threshold is reached. The capacitor bank 230 then releases its stored energy at an appropriate time to generate a high-intensity electromagnetic pulse. Subsequently, the main control board 210 precisely controls the IGBT module 240 to rapidly release the energy in the capacitor bank 230 in the form of pulses, which then flow to the stimulation coil 1 through the diode rectifier 250. This induces a brief, strong pulse current within the stimulation coil 1 and creates a strong magnetic field of 1T to 4T around the stimulation coil 1. Due to its rapid switching response, the IGBT module 240 can generate the required pulse voltage in a short time, thereby creating a strong electromagnetic pulse around the stimulation coil 1. By adjusting the pulse output voltage of the IGBT module 240, the intensity of the electromagnetic field can be precisely controlled, achieving precise stimulation of different depth regions.
[0035] The efficient synergy of these components ensures that the system can generate precise pulsed electromagnetic fields based on specific parameters preset by the clinical operator.
[0036] During the design process, special attention was paid to the stability and reliability of power management to ensure that the device can provide a stable voltage output in different clinical environments. At the same time, to ensure operational safety, multiple protection mechanisms were incorporated into the circuit design, including overcurrent protection and short-circuit protection. The selection of the IGBT module 240 fully considered its fast switching capability, which is crucial for generating high-efficiency pulsed electromagnetic fields. To improve the treatment effect, the transcranial magnetic stimulation system also integrates an intelligent microprocessor, which can monitor and adjust stimulation parameters such as pulse width, frequency and intensity in real time to adapt to the personalized treatment needs of different patients.
[0037] The stimulation mode supports two modules: single-pulse mode and intermittent continuous pulse mode. The single-pulse mode is particularly suitable for initial verification of electric field properties, allowing researchers to precisely control and assess the effects of a single pulse on brain activity. This mode is crucial for understanding the distribution and mechanisms of electromagnetic fields in the brain. The intermittent continuous pulse mode is designed for repetitive transcranial magnetic stimulation (rTMS), a technique widely used in medical practice and scientific research. By setting a series of continuous pulses, the intermittent continuous pulse mode can simulate the brain's neural activity patterns in a natural state, thereby modulating the function of specific brain regions during treatment. This mode is particularly suitable for long-term treatment processes, such as the clinical treatment of depression, anxiety, and other neuropsychiatric disorders. Two modes are provided to accommodate different needs and treatment goals.
[0038] Each stimulation coil 1 is fixed on a heat dissipation component 4, which is used to dissipate heat from the stimulation coil 1 to achieve effective thermal management and prevent deformation of the stimulation coil 1 during use.
[0039] The power supply unit 2 also integrates a temperature monitoring function, which can detect the operating temperature of the equipment in real time to ensure that it operates within a safe range, thus providing dual protection for operators and subjects.
[0040] The heat dissipation component 4 includes an aluminum block with grooves on it that match the stimulation coil 1. The stimulation coil 1 is located in the grooves on the aluminum block and is fixed with epoxy resin. Cutting the aluminum block to match the size of the stimulation coil 1 can ensure good heat dissipation without affecting the magnetic field distribution of the stimulation coil 1.
[0041] The main control board 210 is electrically connected to the computer 3, which is also equipped with a user-friendly interface, allowing the operator to easily set and adjust stimulation parameters, such as pulse count, frequency, and intensity, to achieve the best therapeutic effect.
[0042] The stimulation coil 1 is placed close to the skull model 6, for example, at a distance of 3mm from the skull model 6. Of course, it can also be 4mm, 5mm, etc. This is just an example.
[0043] Example 5 like Figure 7 , Figure 8 , Figure 9 As shown, a transcranial cell stimulation experimental method, using the transcranial cell stimulation experimental model described in any of Examples 1 to 4, includes the following steps: S10. First, the cultured SH-SY5Y cells are pretreated with retinoic acid (RA) to promote the differentiation of SH-SY5Y cells into neuron-like cells, and then placed in a cell culture dish at the corresponding depth under the scalp. S20. The power supply unit 2 is used to rapidly discharge to the two stimulation coils 1 to induce a brief strong pulse current in the stimulation coils 1 and form a strong magnetic field of 1T to 4T around the stimulation coils 1. The generated strong magnetic field stimulates SH-SY5Y cells in the cell culture dish. Then, Western blot technology is used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation.
[0044] Previous studies have shown that TMS (Transcranial Motion Suppression) technology induces currents in the subcortical brain by generating a rapidly changing magnetic field through an electromagnetic coil placed above the scalp, thereby modulating neuronal activity. TMS not only alters cortical excitability during stimulation but also allows these changes to persist after stimulation ceases, suggesting that its effects may be related to neuronal plasticity mechanisms. In particular, long-term potentiation (LTP) and long-term depression (LTD) are two types of synaptic plasticity alterations that constitute the biological basis for the lasting effects of TMS. LTP is the most widely studied form of synaptic plasticity in neuroscience, typically induced in vitro through high-frequency stimulation of neuronal populations. LTP is divided into two phases: early LTP (E-LTP) and late LTP (L-LTP). E-LTP does not depend on new protein synthesis and occurs rapidly after stimulation, while L-LTP requires new protein synthesis and can induce structural and functional changes lasting longer than 24 hours. 2+ The CaMKII-CREB signaling pathway plays a crucial role in the function and plasticity of nerve cells. It is involved in the regulation of various physiological processes such as cellular activity, learning, and memory. Activation of this pathway is usually triggered by external signals. For example, nerve impulses or other extracellular stimuli lead to the formation of calcium ions (Ca). 2+The protein flows into the cell and activates calcium / calmodulin-dependent protein kinase II (CaMKII). Activated CaMKII enhances its activity by autophosphorylating and phosphorylating cyclic adenosine monophosphate effector element binding protein (cAMP-response-binding protein, CREB). As a transcription factor, CREB can regulate the expression of specific genes, thereby affecting the survival, differentiation, and regeneration of neurons.
[0045] In TMS applications, by adjusting Ca 2+ The CaMKII CREB signaling pathway can influence the occurrence of LTP and LTD, thereby producing therapeutic effects on cognitive function and neurodegenerative diseases. For example, studies have shown that TMS can improve learning and memory by enhancing LTP in the hippocampus, and can also counteract synaptic loss in some neurodegenerative diseases by regulating L-LTP.
[0046] Therefore, SH-SY5Y cells are used as the experimental subject in this invention. The SH-SY5Y cell line is derived from human neuroblastoma and possesses morphological, physiological, and biochemical characteristics similar to neurons. SH-SY5Y cells can be induced to differentiate into cells resembling mature neurons under in vitro conditions. This characteristic makes them an ideal tool for studying neuronal activity and the expression of neuronal-related proteins. The main advantages of SH-SY5Y cells are their ease of culture and differentiation, and their ability to mimic the electrophysiological characteristics of neurons after differentiation. The neuron-like features exhibited by these cells after differentiation, including electrochemical signal transduction and responses to neurotransmitters, provide a controllable experimental platform for studying the effects of TMS on neuronal activity. Furthermore, the wide applicability and well-defined characteristics of the SH-SY5Y cell line facilitate the comparison and verification of experimental results.
[0047] In summary, TMS affects Ca 2+ The CaMKII-CREB signaling pathway regulates neuronal plasticity, thereby playing a role in the treatment of cognitive dysfunction and neuropsychiatric disorders.
[0048] like Figure 10 As shown, this study compares the effects of two different TMS coil designs—stimulation coil 1 of this invention and a commercial figure-eight coil—on the expression of phosphorylated cAMP response element binding protein (p-CREB) and CaMKII in the SH-SY5Y cell line, particularly under different deep brain stimulation conditions.
[0049] An experiment was designed to assess the effects of different depths of nerve stimulation. SH-SY5Y cells were placed in culture dishes at depths of 1 cm and 5 cm simulating scalp depth. These dishes were then placed under two different types of TMS coils for stimulation. By comparing the effects of the two coils at different depths on the expression of p-CREB and CaMKII proteins in SH-SY5Y cells, the aim was to reveal the influence of different coil designs on neuronal activity and the expression of proteins related to neural plasticity. p-CREB and CaMKII, as key transcription factors for neural plasticity, reflect the impact of TMS on neuronal function. Analyzing cellular responses at different depths will provide a better understanding of the deep stimulation capabilities of TMS coils, which is crucial for optimizing TMS treatment protocols and improving their effectiveness in clinical applications.
[0050] During cell culture, SH-SY5Y cells were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco, Rockville, MD, USA), a low-glucose formulation to meet the energy metabolism requirements of the cells. To support cell growth and maintain their biological characteristics, 10% fetal bovine serum (FBS, Serum Source International, Charlotte, NC, USA) and 1% penicillin-streptomycin solution (Gibco, Rockville, MD, USA) were added to the medium. Cell culture was carried out at a constant temperature of 37°C, and the incubator was maintained in a humid environment of 5% CO2 to simulate the in vivo environment. When the confluence of the SH-SY5Y cell population reached 80%, cell separation was performed using a 0.25% trypsin-EDTA mixture (Gibco brand). The isolated cells were collected in centrifuge tubes and deposited under decelerated centrifugation. After removing the supernatant, the cells were washed with PBS buffer to remove any remaining trypsin-EDTA. The cells were then resuspended in fresh DMEM medium and transferred to new culture containers at an appropriate ratio. The transferred cells were placed in an incubator at 37°C and 5% CO2 to encourage reattachment and growth. To ensure sterility and adequate nutrition, the culture medium was changed every 2–3 days. During the culture period, cell morphology and growth were regularly examined using an inverted microscope, and the culture data were recorded in detail. Before stimulation, SH-SY5Y cells were pretreated with retinoic acid (RA). RA, as an important cell differentiation inducer, can promote the differentiation of SH-SY5Y cells into neuron-like cells and enhance their neuronal characteristics. The pretreatment step is crucial for subsequent magnetic stimulation experiments.
[0051] The TMS cell protocol referenced the clinically commonly used rTMS protocol to simulate the parameter settings in clinical treatment. The experiment involved stimulation according to the aforementioned groupings, with each group receiving the same stimulation pattern. Each group was repeated four times, using a frequency of 20 Hz and a duration of 30 minutes, with stimulation performed once daily for three consecutive days. This protocol is based on parameters proven effective in modulating neuronal activity in previous studies. To control experimental variables, a sham stimulation group was also included. Cells in this group were placed in the same experimental environment but did not directly receive magnetic field stimulation from the coil. Throughout the stimulation process, consistency of all experimental conditions was ensured, including ambient temperature, humidity, and light.
[0052] To investigate the expression levels of p-CREB and CaMKII in cellular responses, Western blot was employed. First, after reaching an appropriate number of passages, cells were fixed in pre-chilled PBS buffer containing 1% formaldehyde to maintain the native state of proteins. Following fixation, cells were collected and centrifuged to precipitate the protein, then treated with lysis buffer containing inhibitors to separate total protein. After treatment, cell samples were incubated at ice-cold to ensure complete lysis and protein release. Insoluble matter was removed by centrifugation, and the supernatant was collected. Protein concentration was determined using the BCA protein quantification method to ensure uniform protein content across samples. Subsequently, protein samples were mixed with 4×SDS-PAGE loading buffer and boiled in water for 5 min to denature the proteins. Denatured protein samples were analyzed by SDS-PAGE gel electrophoresis, sorted according to molecular weight, and the resulting proteins were transferred to PVDF membranes for further analysis. Subsequently, the membrane was treated in a blocking solution rich in bovine serum albumin to reduce nonspecific binding. After this treatment, the membrane was incubated overnight at 4°C with p-CREB and CaMKII primary antibodies. After the primary antibody reaction, the membrane was repeatedly washed with PBS-T to remove unbound primary antibody. Next, the membrane was incubated with HRP-conjugated secondary antibody at room temperature for 1-2 hours. After the secondary antibody incubation was complete, the membrane was washed again with PBST to remove excess secondary antibody. Finally, chemiluminescent substrate was used for development, and the signal was captured using an X-ray film imaging system to quantitatively analyze the expression levels of p-CREB and CaMKII. For internal calibration, β-actin protein expression was also detected.
[0053] Western blot was used to quantitatively analyze the expression levels of p-CREB and CaMKII in SH-SY5Y cells under different coil stimuli. The experiment focused on the activation effects of two coil designs—stimulation coil 1 of this invention and a commercial figure-eight coil—on intracellular signal transduction pathways. Stimulation depth, a key parameter affecting electromagnetic field penetration and biological effects, was set at two levels: 1 cm and 5 cm to simulate stimulation conditions in superficial and deep brain regions. At a stimulation depth of 1 cm, Western blot results showed that both the double-elliptical stimulation coil 1 and the commercial figure-eight coil significantly increased the levels of p-CREB and CaMKII in SH-SY5Y cells. The experimental results are shown below. Figure 11 As shown, this indicates that these two coils affect Ca during shallow stimulation. 2 + The CaMKII-CREB signaling pathway has a similar activation effect.
[0054] It is noteworthy that when the stimulation depth increased to 5 cm, the experimental data showed significant differences. Specifically, the double elliptical stimulation coil 1 was still able to effectively promote the expression levels of p-CREB and CaMKII, demonstrating its powerful function in deep brain region neuromodulation. In contrast, the commercially available figure-eight coil showed a significantly reduced effect at the same stimulation depth, with no significant difference compared to the control group. This result highlights the unique advantage of the double elliptical stimulation coil 1 in performing deep brain region neuromodulation. Compared to the commercially available figure-eight coil, the double elliptical coil can more effectively cover and stimulate brain regions at a depth of 5 cm below the scalp. Therefore, the double elliptical stimulation coil 1 has extremely high potential value in future neuroscience research and clinical applications, especially in situations requiring deep brain stimulation.
[0055] In summary, it is clear that the double elliptical stimulation coil 1 has a significant effect on Ca2+ in deep brain stimulation. 2+ The activation of the CaMKII CREB signaling pathway provides a new perspective and potential clinical application strategies for the regulation of deep brain nuclei in the future. These findings not only enrich our understanding of non-invasive brain stimulation techniques, but also provide new scientific evidence for the treatment of related neuropsychiatric diseases.
[0056] Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of the present invention.
Claims
1. A transcranial cell stimulation experimental model, characterized in that, include: The support structure (5) and the skull model (6) with an openable skull are provided. The support structure (5) is used to support the skull model (6) and its upper end enters the skull model (6). A placement platform (7) fixed on the support structure (5) and adjustable in angle and height is arranged inside the skull model (6). Cell culture dishes are placed on the placement platform (7). A stimulation coil (1) is arranged on each side of the skull model (6). The stimulation coil (1) is elliptical. Each stimulation coil (1) is electrically connected to the power supply unit (2). The power supply unit (2) is used to rapidly discharge to the two stimulation coils (1) to induce a short-term strong pulse current in the stimulation coil (1) and form a strong magnetic field of 1T to 4T around the stimulation coil (1).
2. The transcranial cell stimulation experimental model according to claim 1, characterized in that, The skull model (6) is formed by three-dimensional printing and its material is polylactic acid.
3. A transcranial cell stimulation experimental model according to claim 1 or 2, characterized in that, The support structure (5) includes: a column (510) and a base (520). The base (520) is located outside the skull model (6). The lower end of the column (510) is located outside the skull model (6) and is fixed to the base (520). The upper end of the column (510) penetrates from below the back of the skull model (6) and enters the skull model (6). The placement platform (7) has at least one assembly hole that matches the diameter of the column (510). The placement platform (7) is fitted onto the column (510) through the assembly hole. A limiting rod is provided on the column (510) radially below the placement platform (7). Multiple washers are fitted on the column (510) between the limiting rod and the placement platform (7).
4. A transcranial cell stimulation experimental model according to claim 1, 2, or 3, characterized in that, The stimulation coil (1) is formed by spirally winding a wire into an elliptical shape, or by stacking multiple elliptical coils in a concentric manner; the material of the stimulation coil (1) is copper, with 6 turns, a short inner diameter of 5mm to 15mm, a long inner diameter of 15mm to 40mm, a wire width of 1.5mm, a wire height of 1mm, an axial spacing of 2mm, and a radial spacing of 1mm.
5. The transcranial cell stimulation experimental model according to claim 1, characterized in that, The power supply unit (2) includes: a main control board (210), two DC-DC boost modules (220), two capacitor banks (230), two IGBT modules (240), and two diode rectifiers (250). The main control board (210) is electrically connected to the two DC-DC boost modules (220), and each of the two DC-DC boost modules (220) is electrically connected to a switching power supply (260). The two switching power supplies (260) are each connected to a 220V AC mains power supply. Each of the two DC-DC boost modules (220) is electrically connected to a capacitor bank (230) and charges the capacitor bank (230). The voltage is made to reach a threshold of 400V to 1000V; each of the two capacitor banks (230) is electrically connected to an IGBT module (240), each of the two IGBT modules (240) is electrically connected to a diode rectifier (250), and each of the two diode rectifiers (250) is electrically connected to a stimulation coil (1); the energy in the capacitor banks (230) is rapidly released in the form of pulses through the IGBT module (240), and flows to the stimulation coil (1) through the diode rectifier (250) to induce a short-term strong pulse current in the stimulation coil (1) and form a strong magnetic field of 1T to 4T around the stimulation coil (1).
6. The transcranial cell stimulation experimental model according to claim 1, characterized in that, The stimulation coil (1) is placed close to the skull model (6).
7. A transcranial cell stimulation experimental method, characterized in that, The transcranial cell stimulation experimental model as described in any one of claims 1 to 6 includes the following steps: S10. First, the cultured SH-SY5Y cells are pretreated with retinoic acid (RA) to promote the differentiation of SH-SY5Y cells into neuron-like cells, and then placed in a cell culture dish at the corresponding depth under the scalp. S20. The power supply unit (2) is used to rapidly discharge to the two stimulation coils (1) to induce a short-term strong pulse current in the stimulation coil (1) and form a strong magnetic field of 1T to 4T around the stimulation coil (1). The generated strong magnetic field stimulates the SH-SY5Y cells in the cell culture dish. Then, Western blot technology is used to quantitatively analyze the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation.
8. The transcranial cell stimulation experimental method according to claim 7, characterized in that, The SH-SY5Y cell culture method is as follows: SH-SY5Y cells were placed in DMEM medium with 10% fetal bovine serum and 1% penicillin-streptomycin solution added, and cultured at a constant temperature of 37°C. The incubator was kept in a humid environment of 5% CO2 to simulate the in vivo environment. When the SH-SY5Y cell population reached 80% confluence, cell separation was performed using a 0.25% trypsin-EDTA mixture. The separated cells were collected in centrifuge tubes and then deposited under decelerated centrifugation. After removing the supernatant, the cells were washed with PBS buffer solution to remove the remaining trypsin-EDTA. Cells were resuspended in fresh DMEM medium and transferred to new culture containers at an appropriate ratio. The transferred cells were placed in a 37°C, 5% CO2 incubator to encourage them to reattach and grow. The culture medium was changed every 2 to 3 days. During the culture period, the cell morphology and growth were checked regularly using an inverted microscope, and the culture data were recorded in detail.
9. A transcranial cell stimulation experimental method according to claim 8, characterized in that, The stimulation pattern for SH-SY5Y cells was as follows: stimulation was performed once a day for 3 consecutive days at a frequency of 20 Hz for a duration of 30 min.
10. A transcranial cell stimulation experimental method according to claim 8, characterized in that, The following is a method for quantitatively analyzing the expression levels of p-CREB and CaMKII proteins in SH-SY5Y cells under magnetic stimulation using Western blot technology: First, after reaching an appropriate number of passages, cells were fixed using pre-cooled PBS buffer containing 1% formaldehyde to maintain the native state of proteins. After fixation, cells were collected and centrifuged to precipitate the protein, followed by treatment with lysis buffer containing inhibitors to separate total protein. After treatment, cell samples were incubated under ice-cold conditions to ensure complete cell breakdown and protein release. Insoluble matter was removed by centrifugation, the supernatant was collected, and protein concentration was determined using the BCA protein quantification method. Subsequently, the protein samples were mixed with 4×SDS-PAGE loading buffer and boiled in water for 5 min to denature the proteins. The denatured protein samples were analyzed by SDS-PAGE gel electrophoresis and sorted according to their molecular weight. After the electrophoresis process, the obtained proteins were transferred to a PVDF membrane for further analysis. Subsequently, the membrane was treated in a blocking solution rich in bovine serum albumin to reduce nonspecific binding. After this treatment, the membrane was incubated overnight at 4°C with p-CREB and CaMKII primary antibodies. After the primary antibody reaction, the membrane was repeatedly washed with PBS-T washing solution to remove unbound primary antibodies. Next, the membrane and HRP-conjugated secondary antibody were incubated at room temperature for 1-2 hours. After the secondary antibody incubation was completed, the membrane was washed again with PBS-T washing solution to remove excess secondary antibody. Finally, chemiluminescent substrates were used for development, and signals were captured using an X-ray film imaging system to quantitatively analyze the expression levels of p-CREB and CaMKII, while also detecting β-actin protein expression.
